3-[(2,6-Dichlorophenyl)methyl]-3H-purin-6-amine is a small molecule compound based on a purine skeleton. 3-[(2,6-Dichlorophenyl)methyl]-3H-purin-6-amine acts as an orally effective, non-competitive, selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP). Acting in the liver, it enhances insulin signal transduction and can be used in research on obesity-associated type 2 diabetes and insulin resistance.